PHOTON

Clinical Trials // Diabetic Macular Edema // Mihai Mititelu // Past // Sep 28 2020

A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients with Diabetic Macular Edema (PHOTON)

Sponsor: Regeneron Pharmaceuticals

CLINICALTRIALS.GOV